Pricing Log in Create free account

Dare Bioscience, Inc. (DARE) vs NewcelX Ltd. (NCEL)

Dare Bioscience, Inc. and NewcelX Ltd. are both Biotechnology companies. Dare Bioscience, Inc. and NewcelX Ltd. are of similar size ($15.3M and $14.6M). NewcelX Ltd. has the higher net margin (0.00% vs −804.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, NewcelX Ltd. leads on 7 and Dare Bioscience, Inc. on 4.

Valuation

Metric DARE NCEL Biotechnology median
P/E n/m n/m 8.50
P/S 7.85 n/m 9.71
P/B n/m 4.61 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.73 n/m 9.21
Earnings yield (97.22%) (61.20%) (33.15%)
Free cash flow yield (108.22%) (17.60%) (25.50%)

Profitability

Metric DARE NCEL Biotechnology median
Gross margin 58.84% 0.00% 65.16%
Operating margin (813.35%) — 0.00%
Net margin (804.33%) 0.00% 0.00%
Free cash flow margin (849.36%) 0.00% 0.00%
Return on equity 165.29% 0.00% (56.36%)
Return on assets (62.16%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DARE NCEL Biotechnology median
Revenue growth (TTM) 7,817.51% — 6.02%
EPS growth (last fiscal year) (150.00%) 11.18% 30.26%
Revenue growth, 5-year CAGR 66.71% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DARE NCEL Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 0.99 0.40 4.72
Net debt to EBITDA 2.07 0.74 0.96

Dividend

Metric DARE NCEL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DARE NCEL Biotechnology median
Market cap 14.56m 15.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack